Delivery Order SPE2DB20D3303-SPE2DB25FA2EU
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $20,776.45 on June 11, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 12, 2025, to be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a ceiling value of $1,783.60. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract through open competition. The order is scheduled for completion by July 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $1,463.13. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $8,006.80. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs across military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count units) valued at $1,488.86. This firm fixed-price delivery order is expected to reach completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $21,098.76. This firm fixed-price delivery order, which has an ultimate completion date of June 3, 2025, carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a competitively awarded contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120 count) with a contract ceiling value of $96,424.70. This competitive award employs firm fixed pricing and requires completion by September 12, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $3,398.61 to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 500 mg tablets (60-count units) on June 12, 2025, with completion scheduled for June 13, 2025. The contract utilizes firm fixed price terms and is not designated as a set-aside award, indicating it was competitively awarded. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60 count) with a ceiling value of $13,456.36. This is a firm fixed price delivery order with no set-aside designation, completed competitively, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of September 10, 2025. The award represents a single delivery order issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,539.30 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count). This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by June 3, 2025. The award represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2EUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Abiraterone Acetate 500 mg, valued at $7,898.12 under a firm fixed price contract. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's contract portfolio with DLA demonstrates its established capability as a critical vendor for federal medical procurement, particularly serving Defense Health Agency and U.S. Coast Guard healthcare systems with specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 8/5/25 |